A convenient and efficient method for the synthesis of new unsaturated spiro-annulated N-aryl-4,6-dioxopyrimidine-2-thione derivatives has been developed. The resulting compounds can be potential biological active molecules or precursors for further chemical modification.
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Barbituric acid derivatives have been shown to be a class of biologically significant heterocycles with a broad spectrum of pharmacological and physiological activities. Therefore, they are widely used in medicinal chemistry and drug discovery. The spiro analogs of (thio)barbituric acids have attracted significant attention in recent time since they show a wide range of activities, such as hypnotic and sedative [1] [2] [3] , anticonvulsant [4] , antibacterial [3, 5] , anticancer [6] , antifungal [5, 7] , urease inhibitor [8] and others. Moreover, in many cases, spirobarbiturates have the higher therapeutic index than linear derivatives [2, 9, 10] . The possibility to obtain unsaturated spirobarbituric acids by ring-closing metathesis (RCM) were shown by Kotha and co-workers [11] . Their protocol was applied for the synthesis of 1,3-dialkyl-5,5-spirobarbiturates and some thiobarbiturates by RCM using the first generation Grubbs catalyst [12] . Recently, we have reported the synthesis of new spyrocyclic pyrimidinetriones with various aliphatic, heteroaliphatic, aromatic and functionalized substituents in positions 1 and 3 on the pyrimidine moiety from the corresponding 5,5-diallyl-or allylmetallyl-substituted derivatives via RCM [13] . It should be noted that the most effective catalyst for metathesis is the phosphine-free Grubbs-Hoveyda type complex. Herein, we present the convenient and effective method for the synthesis of new unsaturated spirocyclic N-aryl-substituted 4,6-dioxopyrimidine-2-thione derivatives.
The target spirocyclic molecules of N-aryldioxopyrimidine-2-thiones were prepared in 3 steps. In the beginning by condensation of disubstituted thioureas 1a-f with commercially available allylmalonic acid 2 the series of monoallyl-substituted thiobarbituric acids 3a-f were synthesized (Scheme 1). The corresponding thioureas were prepared from phenyl-or 4-tolylisothiocyanates and appropriate aliphatic and aromatic amines [14] . The condensation of malonic acid 2 with disubstituted arylthioureas 1a-f were carried out utilizing acetic anhydride or acetyl chloride as dehydrating agents. The reactions with acetic anhydride were carried out at 110 °C for 3 h. At the same time, the use of acetyl chloride allowed decreasing the reaction temperature (60 °C) and making shorter the reaction time (45 min) (Tab. 1). The application of acetyl chloride has additional advantages. Firstly, it increases the yield of title compounds, and secondly, this method enables to form a minimal quantity of by-products.
In some cases the resulting thiobarbiturate derivatives were purified from impurities by column chromatography with silica gel using the mixture of benzene-hexane (3 : 1) as an eluent.
The next step was the synthesis of 5,5-dialkenylsubstituted dioxothiopyrimidines 6a-h by C-alkylation of the resulting compounds 3a-f with аllyl bromide 4 or 2-methyl-3-chloro-1-propene (metallyl chloride) 5 (Scheme 2). In the case of allyl bromide 4 the reaction I was performed in dry acetonitrile in the presence of anhydrous K 2 CO 3 as a base. 2-Methyl-3-chloro-1-propene 5 was less active than allyl bromide 4 and more sterically hindered, and therefore, for alkylation of barbiturates 3a, b potassium tert-butoxide was used as a strong base. The attempts to use potassium carbonate or sodium ethoxide did not lead to formation of desirable products. Alkylation of compound 3a,b with metallyl chloride 5 were performed in a highly polar aprotic solvent DMSO at 65 o C for 12-18 h (TLC control). The target 5,5-dialkenylsubstituted thiobarbiturates 6a-h were purified by column chromatography with silica gel using the mixture of benzene-hexane (3 : 1) as an eluent. Yields of 6a-h are listed in Tab. 2.
In order to convert 5,5-dialkenylthiobarbiturates 6a-h into the corresponding spiro-annulated derivatives 7a-h the ring-closing metathesis (RCM) was applied (Scheme 3). The phosphine-free Grubbs-Hoveyda type catalyst 8 was used for RCM. Upon the treatment with the ruthenium complex 8 (3-5 Mol. %) synthesized according to the known Hoveyda protocol [15] compounds 6a-h were transformed into the corres- ponding spiro-annulated derivatives 7a-h with over 70 %. Yields of the spirocyclic derivatives 7a-h obtained are presented in Tab. 3. The spirane ring was formed in the mixture of dichloromethane and toluene in the argon atmosphere at 40 °C for 2-3 h (Scheme 3). The concentration of the catalyst depends on allyl or methylallyl moieties on the thiobarbituric ring. More sterically hindered substrates demand the increase of the catalyst concentration. Products of metathesis were separated from the catalyst by column chromatography on silica gel using dichloromethane as an eluent, and the resulting crude thiopyrimidines 7a-h were recrystallized from ethanol or the ethyl acetate-hexane mixture.
The synthetic route of RCM cyclization developed has some advantages compared to the protocols previously described. First of all, the reaction proceeds at moderate temperature (40 °C ) and for relatively short time (2-3 h С NMR signals were assigned by using АРТ method. Chemical shifts were reported in ppm downfield from TMS ( 1 H, 13 C) as an internal standard. Elemental analysis was performed in the Analytical laboratory at the Institute of Bioorganic Chemistry and Petrochemistry of the NAS of Ukraine. Melting points were determined on a Boetius hot stage apparatus. The reaction progress was controlled by TLC on Silufol UV-254 plates using the mixture of benzene-acetonitrile (4 : 1) as an eluent. Purification of the compounds obtained was performed by column chromatography using silica gel 60 (particle size of 0.04-0.063 mm, 230-400 mesh).
5-Allyl-1-phenyl-4,6-dioxopyrimidine-2-thione derivatives 3a-f were prepared by condensation of allylmalonic acid with disubstituted arylthioureas in the presence of dehydrating agents -acetic anhydride (method A) or acetyl chloride (method B). Method A (Exemplified by the synthesis of 3a).
5-Allyl-1,3-diphenyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (3a).
To the mixture of 1,3-diphenylthiourea 1a (2.28 g, 10 mmol) and 3-allylmalonic acid 2 (1.44 g, 10 mmol) add acetic anhydride (3.80 g, 40 mmol), heat the resulting suspension and vigorously stir for 3 h at 110 °C. After completion of the reaction (TLC control) evaporate the excess of anhydride and acetic acid under reduced pressure, and pour the residue into cold water to precipitate a crude yellow product. Basificate the suspension to pH = 12 and stir with activated charcoal for 1 h, filter the mixture, and acidify the resulting solution with 15% aqueous hydrogen chloride to pH = 2. Collect the product by filtration and recrystallize from ethyl acetate-hexane or ethanol to provide the title thiopyrimidine 3a as pale yellow crystals (1.14 g, 34% The monoallyl substituted thiobarbiturates 3a-f obtained were converted to the corresponding dialkenyl derivatives 6a-h by alkylation of the active position 5 with allyl bromide 4 (method C) or 2-methyl-3-chloro-1-propene (metallyl chloride) 5 (method D).
Method C (Exemplified by the synthesis of 6a).
5,5-Diallyl-1,3-diphenyl-2-thioxodihydropyrimidine-4,6(1H,5H)-dione (6a).
To the suspension of 5-allyl-1,3-diphenyl-2-thiopyrimidine-4,6-dione 3a (0.67 g, 2.0 mmol) and anhydrous potassium carbonate (0.35 g, 2.5 mmol) in dry acetonitrile (5 ml) add dropwise allyl bromide 4 (0.25 g, 2.05 mmol). Heat the mixture with stirring for 3-5 h at 50 °C. After completion of the reaction (TLC control) filter all insoluble compounds, and evaporate the organic solvent. Purify the resulting residue by column chromatography using benzene-hexane (3 : 1) as an eluent to collect the yellow band. Analytically pure compound 6a was obtained by recrystallization from ethanol as a pale yellow solid (0.48 g, 64 %). M. p. -140-142 °C. The general procedure for the synthesis of spirocyclic 4,6-dioxopyrimidine-2-thiones 7a-h. To the solution of compound 6a-h (5.8 mmol) in dry and deoxygenated dichloromethane and toluene (20 mL) add dropwise catalyst 8 (146 mg, 0.24 mmol) in dichloromethane at 40 °C under Ar. Stir the mixture for 2-4 h at the same temperature. After that evaporate the solvent, and separate the crude product from the ruthenium catalyst by column chromatography on silica gel using CHCl 3 as an eluent. Analytically pure compounds 7a-h were obtained by re-crystallization from ethanol. Diphenyl-8-thioxo-7,9-diazaspiro 
7,9-

Conclusions
The general and effective method for the facile synthesis of the novel unsaturated spirocyclic N-aryl-4,6-dioxopyrimidine-2-thiones derivatives has been developed. The synthetical pathway includes the condensation of disubstituted thioureas with allylmalonic acid and the preparation of 5,5-dialkenylsubstituted dioxothiopyrimidines by C-alkylation with аllyl bromide or metallyl chloride. The latter ones are transformed into the corresponding spirocyclic thiobarbituric acids by utilizing the ring-closing metathesis of the phosphine-free third generation Grubbs-Hoveyda catalyst. The spiro-annulated products obtained can find application in biological and pharmaceutical science or as starting substrates for further chemical modification.
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